Explore 3 Stock Ideas & Industry Insights Download Free Report

Deep Medicine Acquisition Corp. Rights

US DMAQR

NoneUSD
0.00(0%)

Last update at 2024-03-05T21:00:45.378524Z

Day Range

--
LowHigh

52 Week Range

0.050.44
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31
Type yearly yearly
Date 2023-03-31 2022-03-31
Income before tax -0.34266M -0.41404M
Minority interest - -
Net income -0.40023M -0.35818M
Selling general administrative 1.91M 0.41M
Selling and marketing expenses - -
Gross profit -0.06000M -0.06000M
Reconciled depreciation - -
Ebit -0.34266M -0.46165M
Ebitda -3.99158M -0.40578M
Depreciation and amortization -3.64892M 0.06M
Non operating income net other - -
Operating income -0.34266M -0.46165M
Other operating expenses 2.17M 0.41M
Interest expense - 0.00827M
Tax provision - -
Interest income - -
Net interest income - -
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense 0.06M -0.05587M
Total revenue - -
Total operating expenses 2.11M 0.41M
Cost of revenue 0.06M 0.06M
Total other income expense net 1.82M 0.05M
Discontinued operations - -
Net income from continuing ops - -
Net income applicable to common shares - -
Preferred stock and other adjustments - -
Breakdown 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31
Total assets 9.78M 128.95M 0.54M
Intangible assets - - -
Earning assets - - -
Other current assets 0.02M 128.08M -
Total liab 7.22M 4.96M 0.55M
Total stockholder equity 2.55M 123.99M -0.00940M
Deferred long term liab - - -
Other current liab 0.93M 0.04M -
Common stock 8.99M 127.77M 0.00029M
Capital stock - - -
Retained earnings -6.44063M -3.77632M -0.05940M
Other liab - - -
Good will - - -
Other assets - - -
Cash 0.60M 0.88M 0.50M
Cash and equivalents - - -
Total current liabilities 2.80M 0.54M 0.04M
Current deferred revenue - - -
Net debt 1.27M -0.37710M -0.00007M
Short term debt 1.86M 0.50M -
Short long term debt - - -
Short long term debt total 1.86M 0.50M 0.50M
Other stockholder equity 0.00038M 0.00006M 0.05M
Property plant equipment - - -
Total current assets 9.78M 128.95M 0.54M
Long term investments - - -
Net tangible assets - - -
Short term investments 9.16M 127.76M -
Net receivables - - -
Long term debt - - -
Inventory - - -
Accounts payable - - -
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total - - -
Capital lease obligations - - -
Long term debt total - - -
Breakdown 2023-03-31 2022-03-31
Type yearly yearly
Date 2023-03-31 2022-03-31
Investments - -
Change to liabilities - -
Total cashflows from investing activities - -
Net borrowings - -
Total cash from financing activities -119.66965M 128.84M
Change to operating activities - -
Net income -0.40023M -0.41404M
Change in cash -0.28156M 0.38M
Begin period cash flow 0.88M 0.50M
End period cash flow 0.60M 0.88M
Total cash from operating activities -1.03644M -0.69787M
Issuance of capital stock - -
Depreciation - -
Other cashflows from investing activities - -
Dividends paid - -
Change to inventory - -
Change to account receivables - -
Sale purchase of stock -121.03465M -
Other cashflows from financing activities 1.36M -0.32510M
Change to netincome - -
Capital expenditures 0.00000M 0.00000M
Change receivables - -
Cash flows other operating - -
Exchange rate changes - -
Cash and cash equivalents changes - -
Change in working capital 1.19M -0.28796M
Stock based compensation - -
Other non cash items -1.82446M 0.00413M
Free cash flow -1.03644M -0.69787M

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
DMAQR
Deep Medicine Acquisition Corp. Rights
- -% - - - - -
DOGEF
Orsted A/S
- -% 22.01 28.82 0.66 6.50 0.07 3.88 15.58
NCRRP
NCR Corp Pref A
- -% 1002.00 1034.35 - - -
TBB
AT&T Inc. 5.35% GLB NTS 66
- -% 20.53 4.60 - - -
CCZ
Comcast Holdings Corp
-0.95 1.45% 64.55 55.07 - - -

Reports Covered

Stock Research & News

Profile

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC.

Deep Medicine Acquisition Corp. Rights

595 Madison Avenue, New York, NY, United States, 10017

  • 917 289 2776

Key Executives

Name Title Year Born
Mr. Humphrey P. Polanen CEO & Chairman 1950
Ms. Weixuan Luo CPA, MS Chief Financial Officer 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.